These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Mechanism of action of papaverine on isolated coronary vessels]. Kukovetz WR; Juan H; Pöch G Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):262-3. PubMed ID: 4310612 [No Abstract] [Full Text] [Related]
26. Proceedings: Effects of papaverine derivatives on cyclic 3', 5'-AMP phosphodiesterase and relaxation of rabbit ileum. Berndt SF; Schulz HU J Neural Transm; 1974; Suppl 11(0):187-93. PubMed ID: 4367522 [No Abstract] [Full Text] [Related]
27. Effects of papaverine derivatives on cyclic 3',5'-AMP phosphodiesterase and relaxation of rabbit ileum. Berndt SF; Schulz HU J Neural Transm; 1974; Suppl 11(0):187-93. PubMed ID: 4370809 [No Abstract] [Full Text] [Related]
28. Platelet aggregation. IV. Platelet phosphodiesterase and its inhibition by vasodilators. Vigdahl RL; Mongin J; Marquis NR Biochem Biophys Res Commun; 1971 Mar; 42(6):1088-94. PubMed ID: 4323846 [No Abstract] [Full Text] [Related]
29. Antispasmodic action of 1-diethylaminoethyl-3-(p-methoxybenzyl)-2-quinoxalone (P 201-1) and its inhibitory effect on cyclic 3',5'-nucleotide phosphodiesterase (PDE) activity. Hayashi S; Ozawa H Chem Pharm Bull (Tokyo); 1975 Apr; 23(4):810-6. PubMed ID: 171085 [No Abstract] [Full Text] [Related]
30. Inhibition of cyclic 3',5'-AMP phosphodiesterase in islet cells and other tissues by tolbutamide. Goldfine ID; Perlman R; Roth J Nature; 1971 Dec; 234(5327):295-7. PubMed ID: 4333163 [No Abstract] [Full Text] [Related]
31. Stimulated formation of adenosine 3',5'-monophosphate by desipramine in brain slices. Kodama T; Matsukado Y; Suzuki T; Tanaka S; Shimizu H Biochim Biophys Acta; 1971 Oct; 252(1):165-70. PubMed ID: 4334914 [No Abstract] [Full Text] [Related]
32. Studies of the effect of nicotinic acid on cyclic nucleotide phosphodiesterase activity in rat heart and adipose tissue. Therriault DG; Winters VG Life Sci I; 1970 Apr; 9(8):421-8. PubMed ID: 4323330 [No Abstract] [Full Text] [Related]
33. Adenyl cyclase and phosphodiesterase activities in brain areas of man, monkey and rat. Williams RH; Little SA; Ensinck JW Am J Med Sci; 1969 Sep; 258(3):190-202. PubMed ID: 4310017 [No Abstract] [Full Text] [Related]
34. Significance of the caffeine-like effect of various purines, pyrimidines and derivatives on adipose-tissue phosphodiesterase. Peers DG; Davies JI Biochem J; 1971 Sep; 124(2):8P-9P. PubMed ID: 4333852 [No Abstract] [Full Text] [Related]
35. A role of cyclic nucleotides in brain metabolism. Goldberg ND; O'Dea RF; Lust WD; Wei S; O'Toole AG Adv Biochem Psychopharmacol; 1970; 3():67-87. PubMed ID: 4331466 [No Abstract] [Full Text] [Related]
36. Accumulation of cyclic adenosine monophosphate in incubated slices of brain tissue. 2. Effects of depolarizing agents, membrane stabilizers, phosphodiesterase inhibitors, and adenosine analogs. Huang M; Shimizu H; Daly JW J Med Chem; 1972 May; 15(5):462-6. PubMed ID: 4402484 [No Abstract] [Full Text] [Related]
37. Cyclic 3',5'-nucleotide phosphodiesterase. Preparation of a partially inactive enzyme and its subsequent stimulation by snake venom. Cheung WY Biochim Biophys Acta; 1969 Nov; 191(2):303-15. PubMed ID: 4311147 [No Abstract] [Full Text] [Related]
38. Inhibition of cyclic 3',5'-adenosine monophosphate phosphodiesterase by substituted imidazopyrazines. Mandel LR Biochem Pharmacol; 1971 Dec; 20(12):3413-21. PubMed ID: 4332205 [No Abstract] [Full Text] [Related]